Questions about this study?
The HopeStage team will email you.
TerminatedNCT04404712
FAAH Availability in Psychiatric Disorders: A PET Study
Medication studyAges 18–65United StatesPTSD
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- New Haven, United StatesSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: September 23, 2020
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 6
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- EARLY Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT04404712
- Official title
Show the full official title
FAAH Availability in Psychiatric Disorders: A PET Study
Recruitment & locations
TerminatedNew Haven
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Does this study involve medication?
Yes. The study involves medication, including [11C]MK-3168.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me